187 related articles for article (PubMed ID: 24652521)
1. Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.
Capelôa T; Caramelo F; Fontes-Ribeiro C; Gomes C; Silva AP
Neurotox Res; 2014 Oct; 26(3):216-27. PubMed ID: 24652521
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Dragojevic S; Mackey R; Raucher D
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
[TBL] [Abstract][Full Text] [Related]
6. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
7. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
8. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
[TBL] [Abstract][Full Text] [Related]
9. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
[TBL] [Abstract][Full Text] [Related]
11. Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth.
Lopes DV; de Fraga Dias A; Silva LFL; Scholl JN; Sévigny J; Battastini AMO; Figueiró F
Purinergic Signal; 2021 Jun; 17(2):273-284. PubMed ID: 33745072
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
[TBL] [Abstract][Full Text] [Related]
13. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier.
Kostka K; Sokolova V; El-Taibany A; Kruse B; Porada D; Wolff N; Prymak O; Seeds MC; Epple M; Atala AJ
Molecules; 2024 May; 29(11):. PubMed ID: 38893345
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Amphiregulin Triggers Doxorubicin-Induced Autophagic and Apoptotic Death by Regulating Endoplasmic Reticulum Stress in Glioblastoma Cells.
Lee IN; Yang JT; Hsieh MJ; Huang C; Huang HC; Ku YJ; Wu YP; Huang KC; Chen JC
J Mol Neurosci; 2020 Oct; 70(10):1461-1470. PubMed ID: 32472393
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
[TBL] [Abstract][Full Text] [Related]
16. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma.
Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J
J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
Toffoli G; Corona G; Gigante M; Boiocchi M
Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
20. Multiple emulsions as effective platforms for controlled anti-cancer drug delivery.
Dluska E; Markowska-Radomska A; Metera A; Tudek B; Kosicki K
Nanomedicine (Lond); 2017 Sep; 12(18):2183-2197. PubMed ID: 28820020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
